Adjusted ORa | 95% CI | p value | |
---|---|---|---|
hsTnT, per 100 ng/L increase | 0.99 | 0.94–1.04 | 0.63 |
CK, per 100U/L increase | 1.01 | 0.93–1.09 | 0.86 |
ST-deviation at presentation | 0.61 | 0.32–1.14 | 0.12 |
Absence of coronary atherosclerosis on ICA | 0.78 | 0.39–1.55 | 0.48 |
Echocardiography performed | 0.76 | 0.36–1.58 | 0.46 |
LVEF ≤ 45% | 1.50 | 0.56–4.02 | 0.42 |
Wall motion abnormalities | 0.74 | 0.32–1.76 | 0.50 |
Additional imaging (composite of CMR, CT-angiography, left ventriculography) | 0.42 | 0.21–0.85 | 0.016 |
CMR performed | 0.43 | 0.17–1.09 | 0.076 |
CT-angiography performed | 0.60 | 0.22–1.63 | 0.31 |
Left ventriculography performed | 0.38 | 0.12–1.20 | 0.097 |
MINOCA with diagnosis | 0.53 | 0.25–1.10 | 0.088 |
Medication at discharge | |||
DAPT | 1.52 | 0.78–2.93 | 0.22 |
Oral anticoagulation | 1.57 | 0.47–5.27 | 0.47 |
Beta-blocker | 0.85 | 0.44–1.63 | 0.62 |
ACE-inhibitor or ARB | 0.51 | 0.27–0.97 | 0.039 |
Statin | 0.97 | 0.48–1.96 | 0.93 |